Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment

R SantosA RuzzaBei WangP MaruffE et alFrederick Raal2024-10-082024-10-08WOS2047-4873https://hdl.handle.net/10539/41427Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatmentJournal Article